Editor’s note

Besides the balanced reasoning within the Delhi HC judgement, it is the SC's intervention which could see this case go down as a…

The last month saw a major milestone in the patent versus patient debate

According to the latest data from the India Brand Equity Foundation (IBEF), the Indian domestic pharma market ended FY15 with a…

Some industry observers are surprised that ‘significant violations’ of this nature have not warranted an import alert or ban

After a decade of pain, there are some reassuring signs that the pharmaceutical industry may just be seeing the faint glimmers of…

With the launch of the Digital India campaign in early July, it is time to relook India Pharma Inc’s engagement with technology

With little known Lee Pharma filing India's third compulsory licensing (CL), legal eagles and everyone interested or connected to…

When governments have to weigh public health against IP issues, LDCs and developing countries really have no choice but to plug…

Two reports, released in early June, have both good news and bad news for the pharma industry in India

Just as 2015 is a make or break year for PM Modi, this will be a decisive year for the pharma sector as well Now that the…